Insider Transactions in Q2 2019 at Cvs Health Corp (CVS)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2019
|
Derica W Rice EVP & President, CVS Caremark |
SELL
Payment of exercise price or tax liability
|
Direct |
3,576
-22.33%
|
$185,952
$52.37 P/Share
|
|
May 16
2019
|
Mary L Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,111
+50.0%
|
$57,772
$52.3 P/Share
|
|
May 16
2019
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+10.75%
|
$115,544
$52.3 P/Share
|
|
May 16
2019
|
Mark T Bertolini Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+15.38%
|
$115,544
$52.3 P/Share
|
|
May 16
2019
|
Richard M Bracken Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+14.52%
|
$121,160
$52.3 P/Share
|
|
May 16
2019
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,366
+2.04%
|
$123,032
$52.3 P/Share
|
|
May 16
2019
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+13.67%
|
$121,160
$52.3 P/Share
|
|
May 16
2019
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,592
+4.19%
|
$290,784
$52.3 P/Share
|
|
May 16
2019
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+50.0%
|
$115,544
$52.3 P/Share
|
|
May 16
2019
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+19.36%
|
$121,160
$52.3 P/Share
|
|
May 16
2019
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+50.0%
|
$115,544
$52.3 P/Share
|
|
May 16
2019
|
Richard J Swift Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,402
+29.79%
|
$124,904
$52.3 P/Share
|
|
May 16
2019
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+6.96%
|
$115,544
$52.3 P/Share
|
|
Apr 01
2019
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
20,858
-5.09%
|
$1,126,332
$54.19 P/Share
|
|
Apr 01
2019
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,336
-2.8%
|
$72,144
$54.19 P/Share
|
|
Apr 01
2019
|
Kevin Hourican EVP & President, CVS Pharmacy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,109
-6.78%
|
$59,886
$54.19 P/Share
|
|
Apr 01
2019
|
Thomas M Moriarty EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,837
-10.05%
|
$261,198
$54.19 P/Share
|
|
Apr 01
2019
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,606
-4.1%
|
$194,724
$54.19 P/Share
|
|
Apr 01
2019
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,411
-7.23%
|
$130,194
$54.19 P/Share
|
|
Apr 01
2019
|
Alan Lotvin EVP&President-PharmacyServices |
SELL
Payment of exercise price or tax liability
|
Direct |
863
-10.22%
|
$46,602
$54.19 P/Share
|
|
Apr 01
2019
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
SELL
Payment of exercise price or tax liability
|
Direct |
742
-3.86%
|
$40,068
$54.19 P/Share
|
|
Apr 01
2019
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
253
-2.69%
|
$13,662
$54.19 P/Share
|
|
Apr 01
2019
|
James David Clark SVP, Cont & Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,536
+28.64%
|
$298,944
$54.19 P/Share
|